Reference Library

The reference library behind every consultation

This page is the complete list of sources a Skin Adviser consultation is allowed to cite: 82 published dermatology references — peer-reviewed journal papers, Cochrane reviews and NICE clinical guidance — each checked against the published record before it earned its place. The rule is simple: if the evidence for a claim isn’t on this page, we don’t make the claim.

By The Skin Adviser team · Published 11 August 2026 · 82 references as of August 2026

The Rule

Why a closed reference list?

Most skincare advice borrows authority it never shows you. “Studies show”, “dermatologist approved”, “clinically proven” — phrases that sound like evidence but lead nowhere. A closed list prevents that failure at the root. Every consultation draws its citations from this fixed bibliography and nothing else, in a form you can look up — (Draelos 2018), for example. If no reference on the list supports a claim, the citation is omitted rather than invented, and vague filler like “studies show” is banned outright.

A closed list has a cost: 82 references will never cover everything dermatology knows. We accept that trade, because what it buys is checkability — any citation you meet in a consultation can be traced back to this page. How the list fits into the rest of the process, from the product database to the safety rules to how we make money, is set out on our methodology page.

The Checking

How were these sources verified?

By hand, one entry at a time, against the published record. Before a reference is allowed onto the list, we confirm that the first author, year and journal match a real publication — searching PubMed, journal archives, the Cochrane Library and NICE’s published guidance — and we record the specific claim the source actually backs. Nothing goes in unverified.

That is why each entry below carries a one-line “supports” note. It pins the reference to the particular claim it is used for in a consultation — not just what we read, but what we rely on it for. And you don’t have to take any of it on trust: the author, year and journal are enough to find each source yourself on PubMed or Google Scholar.

The List

What sources does a consultation cite?

Only the sources on this page. The full list follows, grouped by topic — 82 references as of August 2026, across 9 topics from skin barrier science to pregnancy and breastfeeding safety. Each entry gives the authors, year and journal as cited in consultations, followed by the specific claim it supports.

Skin barrier, moisturisers, ceramides, TEWL & hydration · 14 references

  1. Rawlings & Harding (2004). Dermatol Ther.

    Supports: NMF and lamellar lipids maintain stratum corneum hydration and barrier

  2. Elias (1983). J Invest Dermatol.

    Supports: intercellular lipids form the epidermal permeability barrier (brick-and-mortar)

  3. Bouwstra & Ponec (2006). Biochim Biophys Acta.

    Supports: ceramide/cholesterol/fatty-acid lamellae determine skin barrier function

  4. Del Rosso & Levin (2011). J Clin Aesthet Dermatol.

    Supports: maintaining stratum corneum integrity reduces TEWL and repairs barrier

  5. Verdier-Sévrain & Bonté (2007). J Cosmet Dermatol.

    Supports: NMF and lipids retain water, limiting transepidermal water loss

  6. Papakonstantinou et al. (2012). Dermato-Endocrinology.

    Supports: hyaluronic acid retains skin water and declines with ageing

  7. Draelos (2018). J Cosmet Dermatol.

    Supports: moisturisers boost hydration and deliver barrier-active ingredients

  8. Kraft & Lynde (2005). Skin Therapy Lett.

    Supports: emollients, occlusives and humectants classify moisturiser function

  9. Lodén (2003). Am J Clin Dermatol.

    Supports: emollients reduce TEWL in dry-skin barrier disorders

  10. Coderch et al. (2003). Am J Clin Dermatol.

    Supports: ceramides are the dominant stratum corneum barrier lipid

  11. Sethi et al. (2016). Indian J Dermatol.

    Supports: review of moisturiser science, mechanisms and clinical use

  12. Purnamawati et al. (2017). Clin Med Res.

    Supports: moisturisers restore the impaired barrier in dermatitis

  13. Grubauer et al. (1989). J Lipid Res.

    Supports: TEWL is the signal driving lipid synthesis and barrier recovery

  14. Wertz & Downing (1982). Science.

    Supports: acylceramides rivet lamellae forming the epidermal water barrier

Vitamin C, niacinamide & azelaic acid · 11 references

  1. Pinnell et al. (2001). Dermatol Surg.

    Supports: topical L-ascorbic acid at low pH boosts photoprotection

  2. Telang (2013). Indian Dermatol Online J.

    Supports: vitamin C is antioxidant for photoageing and hyperpigmentation

  3. Al-Niaimi & Chiang (2017). J Clin Aesthet Dermatol.

    Supports: topical vitamin C is antioxidant, photoprotective and antipigmentary

  4. Bissett et al. (2005). Dermatol Surg.

    Supports: 5% niacinamide reduces wrinkles, spots and red blotchiness

  5. Hakozaki et al. (2002). Br J Dermatol.

    Supports: niacinamide suppresses melanosome transfer, reducing pigmentation

  6. Draelos et al. (2006). J Cosmet Laser Ther.

    Supports: 2% niacinamide reduces facial sebum production

  7. Navarrete-Solís et al. (2011). Dermatol Res Pract.

    Supports: 4% niacinamide comparable to hydroquinone for melasma

  8. Fitton & Goa (1991). Drugs.

    Supports: azelaic acid effective for acne and hyperpigmentary disorders

  9. Baliña & Graupe (1991). Int J Dermatol.

    Supports: 20% azelaic acid comparable to 4% hydroquinone in melasma

  10. Matts et al. (2002). IFSCC Mag.

    Supports: review of niacinamide's broad range of effects in skin

  11. Gehring (2004). J Cosmet Dermatol.

    Supports: niacinamide improves barrier, lowers TEWL and raises ceramides

Retinoids, retinol & photoageing · 12 references

  1. Kligman et al. (1986). J Am Acad Dermatol.

    Supports: topical tretinoin partly reverses photoaged skin over 12+ weeks

  2. Weiss et al. (1988). JAMA.

    Supports: double-blind trial: topical tretinoin improves photoaged skin

  3. Griffiths et al. (1993). N Engl J Med.

    Supports: tretinoin restores collagen I formation in photodamaged skin

  4. Fisher et al. (1997). N Engl J Med.

    Supports: UV induces collagen-degrading MMPs; tretinoin inhibits their induction

  5. Mukherjee et al. (2006). Clin Interv Aging.

    Supports: retinoids effective for ageing skin, with irritation caveats

  6. Kang et al. (1995). J Invest Dermatol.

    Supports: topical retinol gives retinoid-like effects with less irritation

  7. Bellemère et al. (2009). Skin Pharmacol Physiol.

    Supports: 0.1% retinol shows anti-ageing molecular and clinical effects

  8. Kong et al. (2016). J Cosmet Dermatol.

    Supports: retinol produces retinoic-acid-like histological changes in skin

  9. Kafi et al. (2007). Arch Dermatol.

    Supports: topical retinol improves naturally aged skin and boosts collagen

  10. Fluhr et al. (1999). Dermatology.

    Supports: retinol and retinaldehyde better tolerated than retinoic acid

  11. Riahi et al. (2016). Am J Clin Dermatol.

    Supports: review of retinoid therapeutic mechanisms in photodamaged skin

  12. Babcock et al. (2015). J Drugs Dermatol.

    Supports: retinol comparably effective and better tolerated than tretinoin

Sunscreen, UV, visible light, PIH & skin of colour · 14 references

  1. Green et al. (1999). Lancet.

    Supports: daily SPF15+ sunscreen cut squamous-cell carcinoma in an RCT

  2. Green et al. (2011). J Clin Oncol.

    Supports: regular sunscreen use reduced melanoma at trial follow-up

  3. Hughes et al. (2013). Ann Intern Med.

    Supports: daily sunscreen use slows skin ageing in an RCT

  4. Diffey (1991). Phys Med Biol.

    Supports: solar UVA/UVB biological effects on human skin

  5. Boukari et al. (2015). J Am Acad Dermatol.

    Supports: visible-light-protective sunscreen prevents melasma relapse

  6. Castanedo-Cazares et al. (2014). Photodermatol Photoimmunol Photomed.

    Supports: adding visible-light protection improves melasma treatment

  7. Dumbuya et al. (2020). J Drugs Dermatol.

    Supports: iron oxides protect skin of colour from visible-light pigmentation

  8. Lyons et al. (2021). J Am Acad Dermatol.

    Supports: tinted sunscreens with iron oxides shield against visible light

  9. Davis & Callender (2010). J Clin Aesthet Dermatol.

    Supports: post-inflammatory hyperpigmentation review in skin of colour

  10. Grimes (2009). Semin Cutan Med Surg.

    Supports: managing hyperpigmentation in darker skin; sunscreen is fundamental

  11. Callender et al. (2011). Am J Clin Dermatol.

    Supports: PIH pathogenesis and treatment in darker skin

  12. Passeron & Picardo (2018). Pigment Cell Melanoma Res.

    Supports: melasma as a visible-light and photoageing pigmentary disorder

  13. Ruvolo et al. (2018). Int J Cosmet Sci.

    Supports: visible light induces pigmentation, requiring broader photoprotection

  14. Silpa-archa et al. (2017). J Am Acad Dermatol.

    Supports: comprehensive PIH overview: epidemiology and pathogenesis

Acne, benzoyl peroxide, adapalene & chemical exfoliation · 10 references

  1. Zaenglein et al. (2016). J Am Acad Dermatol.

    Supports: AAD acne guidelines: benzoyl peroxide and topical retinoids first-line

  2. Thiboutot et al. (2018). J Am Acad Dermatol.

    Supports: combine benzoyl peroxide with a retinoid; limit antibiotic use

  3. Gollnick et al. (2003). J Am Acad Dermatol.

    Supports: consensus: topical retinoid plus benzoyl peroxide for acne

  4. Eichenfield et al. (2013). Pediatrics.

    Supports: evidence-based paediatric acne treatment recommendations

  5. NICE (2021). guideline NG198.

    Supports: UK acne guideline: fixed topical combinations first-line

  6. Sagransky, Yentzer & Feldman (2009). Expert Opin Pharmacother.

    Supports: benzoyl peroxide effective for acne without bacterial resistance

  7. Ozolins et al. (2004). Lancet.

    Supports: topical benzoyl peroxide matches oral antibiotics for acne

  8. Millikan (2001). J Eur Acad Dermatol Venereol.

    Supports: adapalene 0.1% gel effective and better tolerated than tretinoin

  9. Kornhauser et al. (2010). Clin Cosmet Investig Dermatol.

    Supports: AHA/BHA exfoliation mechanisms, benefits and safety

  10. Babilas et al. (2012). J Dtsch Dermatol Ges.

    Supports: glycolic-acid/AHA cosmetic and dermatologic uses including acne

Rosacea · 4 references

  1. van Zuuren et al. (2019). Br J Dermatol.

    Supports: rosacea: ivermectin, azelaic acid and brimonidine effective

  2. van Zuuren et al. (2015). Cochrane Database Syst Rev.

    Supports: topical metronidazole and azelaic acid effective for rosacea

  3. Two et al. (2015). J Am Acad Dermatol.

    Supports: reviews topical and systemic rosacea therapies

  4. Schaller et al. (2020). Br J Dermatol.

    Supports: ROSCO phenotype-based rosacea diagnosis and treatment

Diet, sleep, stress & hormones · 9 references

  1. Oyetakin-White et al. (2015). Clin Exp Dermatol.

    Supports: poor sleep quality linked to increased skin ageing

  2. Kahan et al. (2010). Med Hypotheses.

    Supports: poor sleep may impair skin barrier and repair

  3. Smith et al. (2007). J Am Acad Dermatol.

    Supports: low-glycaemic-load diet improves acne in an RCT

  4. Kwon et al. (2012). Acta Derm Venereol.

    Supports: low-glycaemic-load diet reduces acne lesions and histology

  5. Adebamowo et al. (2005). J Am Acad Dermatol.

    Supports: higher milk intake associated with teenage acne

  6. Juhl et al. (2018). Nutrients.

    Supports: dairy and milk intake associated with acne (meta-analysis)

  7. Chiu et al. (2003). Arch Dermatol.

    Supports: examination stress increases acne severity in students

  8. Thornton (2013). Dermato-Endocrinology.

    Supports: oestrogen loss accelerates skin ageing, collagen loss and dryness

  9. Khunger & Mehrotra (2019). Int J Womens Health.

    Supports: hormonal change drives menopausal and adult female acne

Pregnancy & breastfeeding safety · 2 references

  1. Murase et al. (2014). J Am Acad Dermatol.

    Supports: safety of dermatologic medications in pregnancy and lactation

  2. Bozzo et al. (2011). Can Fam Physician.

    Supports: most topical skincare acts locally with low pregnancy risk

Cleansing, skin pH, hard water & fragrance/irritants · 6 references

  1. Lambers et al. (2006). Int J Cosmet Sci.

    Supports: natural skin surface pH averages ~4.7 (below 5)

  2. Ananthapadmanabhan et al. (2004). Dermatol Ther.

    Supports: harsh surfactant cleansers damage the barrier; mild syndets are gentler

  3. Perkin et al. (2016). J Allergy Clin Immunol.

    Supports: hard water associated with infant atopic dermatitis risk

  4. de Groot & Schmidt (2016). Dermatitis.

    Supports: many essential oils cause fragrance contact allergy

  5. Danby et al. (2018). J Invest Dermatol.

    Supports: hard water increases surfactant deposition and skin irritation

  6. Held & Agner (2001). Acta Derm Venereol.

    Supports: frequent moisturiser use can alter barrier and irritant susceptibility

End of list — all 82 references. If a claim can’t be traced to one of the entries above, a consultation doesn’t make it.

That’s the whole list.

See how these sources appear in a real consultation — every recommendation cites its evidence in the (Author Year) form above, so you can check it against this page.

Read a full sample consultation